Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Tag: CAR T-cell therapy
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
For April 2025, the editors of AACR's 10 journals highlighted studies on evolution in glioblastoma, new cancer treatment approaches,...
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...